Loss of catheter locking solution caused by fluid density

ASAIO Journal

Volumn 51, Issue 3, 2005, Pages 230-235

  Polaschegg, Hans Dietrich ^a  

^a Medical Devices Consultant ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CATHETERS; COAGULATION; DENSITY OF LIQUIDS; HEMODYNAMICS; SOLUTIONS;

ANTICOAGULANT SOLUTION; CLOTTING; FLUID DENSITY; LOCKING SOLUTION;

BIOMEDICAL ENGINEERING;

ANTICOAGULANT AGENT; LOCKING SOLUTION; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BLOOD; CATHETER; GRAVITY; HEMODYNAMICS; MATERIAL COATING; VISCOSITY;

ANTICOAGULANTS; CALIBRATION; CATHETERIZATION, PERIPHERAL; HEPARIN; HUMANS; SOLUTIONS; VISCOSITY;

EID: 18744416011     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000159742.15560.93     Document Type: Article

References (16)

1. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Vascular Access, 2000. Am J Kidney Dis 37(Suppl. 1): 137-181, 2001.
2. Centers for Medicare & Medicaid Services: 2003 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Baltimore, MD: Centers for Medicare & Medicaid Services, December 2003.
3. Rayner HC, Pisoni RL, Gillespie BW, et al: Creation, cannulation and survival of arteriovenous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 63: 323-330, 2003.
4. Polaschegg HD, Shah C: Overspill of catheter locking solution: Safety and efficacy aspects. ASAIO J 49: 713-715, 2003.
5. Sombolos KI, Fragia TK, Bamichas GI, et al: Heparin solution locked in acute hemodialysis catheters: Impact on activated partial thromboplastin time. ASAIO J 49: 287-289, 2003.
6. Polaschegg HD, Sodemann K, Estabrook B: Investigation of the effect of catheter side holes on flow properties and outwash of the locking solution. Proceedings of the 2nd Symposium on Angioaccess for Hemodialysis. Maastricht: Vascular Access Society, 1999, pp.195.
7. Polaschegg HD, Sodemann K: Risks related to catheter locking solutions containing concentrated citrate. Nephrol Dial Transplant 18: 2688-2690, 2003.
8. Ash S: Inventor. Ash Medical Systems, Assignee. Method of enhancing catheter patency using citrate salt catheter lock solution. PCT patent WO0010385. 02.03.00.
9. th Ed. Boca Raton: CRC Press, 1985, pp. D-222-272.
10. Karaaslan H, Peyronnet P, Benevent D, et al: Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis. Nephrol Dial Transplant 16: 2072-2074, 2001.
11. Moore HL, Twardowski ZJ: The air-bubble method of locking central-vein catheters with acidified, concentrated sodium chloride as a bactericidal agent: In vitro studies. Hemodial Int 7: 311-319, 2003.
12. Polaschegg HD: Diffusion study. Hemodial Int 8: 304-305, 2004.
13. Ash SR, Mankus RA, Sutton JM, et al: Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 4: 22-31, 2000.
14. Ash S: Inventor. Ash Medical Systems, Assignee. Catheter lock solution including a photo-oxidant. US patent 20040092890. 13.05.04.
15. Popper KR: Corrobation, or how a theory stands up to tests, in Popper KR, (ed), The Logic of Scientific Discovery. New York: Basic Books, 1959, pp. 251-81.
16. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36: 1539-1544, 2003.